2023. Efficacy and Safety of Apremilast in Patients With Genital Psoriasis: Results From the Phase 3, Randomized, Placebo-Controlled, Double-blind DISCREET Study. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s110. DOI:https://doi.org/10.25251/skin.7.supp.110.